A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
12/2004
12/30/2004	US20040267003 Nucleotide and amino aicd sequences of oocyte factors for altering ovarian follicular growth in vivo or in vitro
12/30/2004	US20040266874 Contains, as active ingredient, arachidonic acid and/or a compound having arachidonic acid as a constituent fatty acid and, particularly, an alcohol ester of arachidonic acid or a triglyceride, phospholipid or glycolipid in which all or a portion of constituent fatty acids are arachidonic acid
12/30/2004	US20040266745 Estrogen-gestagen combination preparations and uses thereof
12/30/2004	US20040266717 Administering polynucleotide capable of modulating an electrical property in a standard cardiac electrophysiological assay; expressing the polynucleotide in the mammal to prevent or treat the cardiac arrhythmia
12/30/2004	US20040266716 Administering polynucleotide capable of modulating an electrical property in a standard cardiac electrophysiological assay; expressing the polynucleotide in the mammal to prevent or treat the cardiac arrhythmia
12/30/2004	US20040265995 Using frizzled-related proteins (FRP) to induce stem cell proliferation for use in treatment of blood, cell proliferative and autoimmune diseases
12/30/2004	US20040265968 Tissue plasminogen activator-like protease
12/30/2004	US20040265898 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof
12/30/2004	US20040265856 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy
12/30/2004	US20040265427 Novel non-antibiotic strategy against ogip infections based on an activated cereal product or ferric quinate
12/30/2004	US20040265350 Ceramic carrier comprising interconnected skeleton of scaffolding and struts having pores; low density; time-release agents; fibroblast-, or transforming growth factors; bone morphogenic proteins, somatotrophin; antibiotics, vitamins, proteins, hormones, radiopacity agents
12/30/2004	US20040265340 Emulsan adjuvant immunization formulations and use
12/30/2004	US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target
12/30/2004	US20040265293 Heating to increase the loading efficiency of trehalose into the platelets; incubating at 37 degrees C.; preserves biological properties of loaded platelets during freeze-drying and rehydration
12/30/2004	US20040265291 Compositions and methods for restoring bacterial flora
12/30/2004	US20040265290 Lactic acid bacteria as agents for treating and preventing allergy
12/30/2004	US20040265287 Myocardial grafts and cellular compositions useful for same
12/30/2004	US20040265284 Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains
12/30/2004	US20040265281 System capable of treating and defining various diseases using stem cells
12/30/2004	US20040265279 Administering to a subject a bacterial strain of Lactobacillus or Bifidobacterium; Cushing's disease, anxiety, psychological disorders
12/30/2004	US20040265277 Agents for treating malignant diseases using the protein YB-1
12/30/2004	US20040265276 Medicinal combination useful for in vivo exogenic transfection and expression
12/30/2004	US20040265273 gene therapy; nucleic acid sequence encoding an amino terminal fragment of urokinase that comprises and epidermal growth factor-like domain; antimetastasis; murine urokinase ATF expressed by tumor cells in an athymic murine model unexpectedly effectively inhibits tumorigenicity
12/30/2004	US20040265271 Reovirus for the treatment of neoplasia
12/30/2004	DE10321823A1 Präparat mit tierischer Gallenflüssigkeit Preparation with animal bile
12/29/2004	WO2004113575A1 Plasmid-free clone of e. coli strain dsm 6601
12/29/2004	WO2004113516A1 Porcine islets cultured with porcine sertoli cells for xenotransplantation
12/29/2004	WO2004113515A2 Tissue modeling in embryonic stem (es) cell system
12/29/2004	WO2004113513A2 Methods and compositions for modulating stem cell growth and differentiation
12/29/2004	WO2004113512A2 Method of generating islet beta-cells from exocrine pancreatic cells
12/29/2004	WO2004113509A1 Lactobacillus casei lc2w strain and its use in antihypertensive aspect
12/29/2004	WO2004112816A1 Fermentation product and process for producing the same
12/29/2004	WO2004112810A1 Pharmaceutical compositions for antidiarrhea
12/29/2004	WO2004112809A1 Composition for lowering serum uric acid level
12/29/2004	WO2004112808A2 Therapeutic use of lipids extracted from mother of pearl
12/29/2004	WO2004112807A1 Leukocyte cell banks
12/29/2004	WO2004112806A1 Composition for treating or preventing neural disorders
12/29/2004	WO2004112790A1 Sponge toxins
12/29/2004	WO2004112775A1 Composition for preventing urinary system infections
12/29/2004	WO2004112509A2 Nutritional formula for optimal gut barrier function
12/29/2004	WO2004112508A1 Infant or follow-on formula
12/29/2004	WO2004112507A1 Infant or follow-on formula
12/29/2004	WO2004112477A1 Processing of platelet-containing biological fluids
12/29/2004	WO2004090121A3 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same
12/29/2004	WO2004087891A8 Lactobacillus fermentum strain and uses thereof
12/29/2004	WO2004065590A3 Activation and expansion of t cells
12/29/2004	WO2003087392A9 Modulation of stem and progenitor cell differentiation, assays, and uses thereof
12/29/2004	WO2002089747A3 Compositions and methods for the therapy and diagnosis of prostate cancer
12/29/2004	EP1491216A1 Drugs comprising protein forming hollow nanoparticles and therapeutic substance to be transferred into cells fused therewith
12/29/2004	EP1491093A2 Multipotent adult stem cells, sources thereof, methods of obtaining and maintaining same, methods of differentiation thereof, methods of use thereof and cells derived thereof
12/29/2004	EP1490686A2 Whitefly ecdysone receptor nucleic acids, polypeptides, and uses thereof
12/29/2004	EP1490492A2 Hybrid hepatocyte growth factor gene having high expression efficiency of two heterotypes of hepatocyte growth factor
12/29/2004	EP1490480A2 Primitive and proximal hepatic stem cells
12/29/2004	EP1490479A1 Dedifferentiated, programmable stem cells having a monocytic origin and the production and use thereof
12/29/2004	EP1490475A2 Muscle cells and their use in cardiac repair
12/29/2004	EP1490473A1 Bacterial spores
12/29/2004	EP1490439A1 A natural non-polar fluorescent dye from a non-bioluminescent marine invertebrate, compositions containing the said dye and its uses
12/29/2004	EP1490386A2 Novel polypeptides and nucleic acids encoding the same
12/29/2004	EP1490112A1 Method and agent for producing therapeutically active blood compositions
12/29/2004	EP1490107A1 Modulating angiogenesis
12/29/2004	EP1490105A2 Multiple and multivalent dna vaccines in ovo
12/29/2004	EP1490103A2 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthama(obstructive lung disease)
12/29/2004	EP1490077A1 A photoprotective orally administrable composition for skin
12/29/2004	EP1490075A2 Bioadhesive directed somatic cell therapy
12/29/2004	EP1490074A2 Mixed- cell gene therapy
12/29/2004	EP1402898B1 Antarticine-nf3 for the treatment and re-epithelialisation of wounds
12/29/2004	EP1379140A4 Production of pancreatic islet cells and delivery of insulin
12/29/2004	EP1267931B1 Rhodamine derivatives for photodynamic diagnosis and treatment
12/29/2004	EP1216048B1 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols
12/29/2004	EP1198242A4 Autologous thrombin
12/29/2004	EP1196616B1 Replication-competent anti-cancer vectors
12/29/2004	EP1161456B1 Ccr5 binding antibody constructs and their use for treating autoimmune diseases
12/29/2004	EP1084251B1 Attenuated pestiviruses
12/29/2004	EP1062321B1 Uses for humane non-autologous mesenchymal stem cells
12/29/2004	EP1033953A4 Method of cross-linking keratin-based films, sheets, and bulk materials
12/29/2004	EP0935651B1 THERAPY FOR alpha-GALACTOSIDASE A DEFICIENCY
12/29/2004	CN1558950A Somatic cell derived embryonic stem cell and its differentiated cell
12/29/2004	CN1558949A Preparing somatic embryo by utilizing rabbit oocyte
12/29/2004	CN1558946A New strain of lactic acid bacterium and edible compositions, drugs and veterinary products containing it
12/29/2004	CN1558776A Solid composition containing bacillus-type non-pathogenic bacterial spores
12/29/2004	CN1557955A Diazocines compound and method for preparing it using slime bacteria fermentation and extraction method
12/29/2004	CN1557837A Process for preparing multi-bioactive substances from cattle colostrum
12/29/2004	CN1557836A Preparation and use for immunosuppressive polypeptides
12/29/2004	CN1557494A Preparation of microorganism resisting biological active component and its application
12/29/2004	CN1557493A Specific antibody for preventing and treating periodontal disease
12/29/2004	CN1557492A Helicobacter Pylori resisting specific immune globulin preparation
12/29/2004	CN1557491A Specific antibody preparation for inhibiting decayed tooth bacteria
12/29/2004	CN1557490A Microorganism infection resisting immune globulin
12/29/2004	CN1557489A Preparation of oral administered immune globulin from whey
12/29/2004	CN1557488A Preparation for treating intractable chronic pain and its preparing process
12/29/2004	CN1557482A Immune function regulating and tumor resisting natural nutrient
12/29/2004	CN1557481A Natural nutrient for preventing and treating iron-deficiency anemia
12/29/2004	CN1557480A Preparation and application of insulin-like growth factors
12/29/2004	CN1557478A Skin, connective tissue and bone growth promoting composition
12/29/2004	CN1557476A Multiple biological activity polypeptide nutrient
12/29/2004	CN1557475A Beautifying and fat reducing nutrients composition
12/29/2004	CN1557474A Blood pressure reducing natural polypeptide nutrient
12/29/2004	CN1557473A Natural nutrient for preventing and treating hypertension and coronary heart disease
12/29/2004	CN1557472A Antineoplastic natural nutrient
12/29/2004	CN1557471A Nutrient for preventing and treating type II diabetes and X-syndrome

1 ... 818 819 820 821 822 823 824 825 826 827 828 829 830 831 832 833 834 835 836 837 838 ... 1259